Nexvet Biopharma plc Insider Trading for November 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Nexvet Biopharma plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Nexvet Biopharma plc for November 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 24 2015 | NVET | Nexvet Biopharma p ... | Farrell Geraldine T | VP Operations, Gene ... | Option Exercise | M | 0.13 | 4,300 | 538 | 5,733 | |
Nov 24 2015 | NVET | Nexvet Biopharma p ... | Farrell Geraldine T | VP Operations, Gene ... | Buy | M | 0.13 | 4,300 | 538 | 21,253 | 17 K to 21.3 K (+25.36 %) |
Nov 24 2015 | NVET | Nexvet Biopharma p ... | GEARING DAVID | Chief Scientific Of ... | Option Exercise | M | 0.13 | 5,600 | 700 | 7,466 | |
Nov 24 2015 | NVET | Nexvet Biopharma p ... | GEARING DAVID | Chief Scientific Of ... | Buy | M | 0.13 | 5,600 | 700 | 279,330 | 273.7 K to 279.3 K (+2.05 %) |
Nov 24 2015 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | CHIEF FINANCIAL OFF ... | Option Exercise | M | 0.13 | 6,000 | 750 | 8,000 | |
Nov 24 2015 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | CHIEF FINANCIAL OFF ... | Buy | M | 0.13 | 6,000 | 750 | 16,000 | 10 K to 16 K (+60.00 %) |
Nov 24 2015 | NVET | Nexvet Biopharma p ... | Heffernan Mark | Chief Executive Off ... | Option Exercise | M | 0.13 | 7,250 | 906 | 9,666 | |
Nov 24 2015 | NVET | Nexvet Biopharma p ... | Heffernan Mark | Chief Executive Off ... | Buy | M | 0.13 | 7,250 | 906 | 19,334 | 12.1 K to 19.3 K (+60.00 %) |
Nov 20 2015 | NVET | Nexvet Biopharma p ... | Heffernan Mark | Chief Executive Off ... | Option Exercise | M | 0.13 | 9,204 | 1,151 | 9,203 | |
Nov 20 2015 | NVET | Nexvet Biopharma p ... | Heffernan Mark | Chief Executive Off ... | Buy | M | 0.13 | 9,204 | 1,151 | 243,587 | 234.4 K to 243.6 K (+3.93 %) |
Nov 19 2015 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | Chief Financial Off ... | Option Exercise | M | 0.13 | 7,080 | 885 | 7,079 | |
Nov 19 2015 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | Chief Financial Off ... | Buy | M | 0.13 | 7,080 | 885 | 14,160 | 7.1 K to 14.2 K (+100.00 %) |
Nov 05 2015 | NVET | Nexvet Biopharma p ... | Farrell Geraldine T | VP Operations, Gene ... | Option Exercise | M | 0.13 | 6,195 | 774 | 6,194 | |
Nov 05 2015 | NVET | Nexvet Biopharma p ... | Farrell Geraldine T | VP Operations, Gene ... | Buy | M | 0.13 | 6,195 | 774 | 16,953 | 10.8 K to 17 K (+57.59 %) |
Nov 05 2015 | NVET | Nexvet Biopharma p ... | GEARING DAVID | Chief Scientific Of ... | Option Exercise | M | 0.13 | 9,204 | 1,151 | 9,203 | |
Nov 05 2015 | NVET | Nexvet Biopharma p ... | GEARING DAVID | Chief Scientific Of ... | Buy | M | 0.13 | 9,204 | 1,151 | 273,730 | 264.5 K to 273.7 K (+3.48 %) |